Entrada Therapeutics Incorporated is a biotechnology company developing Endosomal Escape Vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform is the base for a portfolio of oligonucleotide, antibody, and enzyme-based programs.The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne Muscular Dystrophy and Myotonic Dystrophy-Type 1. The company was known as CycloPorters Inc. until 2017. It was incorporated in 2016 and is headquartered in Boston, MA.
What is Entrada Therapeutics's quote symbol?
What is the 52 week high and low for Entrada Therapeutics (NASDAQ: TRDA)?
How much is Entrada Therapeutics stock worth today?
How much is Entrada Therapeutics's stock price per share?
What is Entrada Therapeutics's Market Cap?